SCHEMBL8224323

SCHEMBL8224323

CC(C)(C)OC(=O)N1CCCC[C@H]1[C@@H](O)c1ccc(-c2cccnc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.51
KDM4D Q6B0I6 1/20 0.43
ADAM17 P78536 1/20 0.41
KDM1A O60341 1/20 0.40
DAGLB Q8NCG7 1/20 0.40
DPP4 P27487 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
GBA1 P04062 1/20 0.40
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
PABPC1 P11940 1/20 0.39
KMT2A Q03164 1/20 0.39
KIT P10721 1/20 0.38
PTGES O14684 2/20 0.38
ACHE P22303 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3442475 0.89 GPR119 (0.47) GPR119KDM4EKMT2AALDH1A1CYP3A4
SCHEMBL4781869 0.89 USP30 (0.43) GPR119KDM1A
SCHEMBL4143386 0.86 GPR119 (0.47) GPR119KDM4ECYP3A4
SCHEMBL4781855 0.84 DAGLB (0.46) ADAM17DAGLBDPP4DPP7KDM4E
SCHEMBL4781860 0.84 DAGLB (0.46) ADAM17DAGLBDPP4DPP7KDM4E
SCHEMBL8221589 0.82 GPR119 (0.43) GPR119KDM4D
SCHEMBL3443002 0.82 GPR119 (0.43) GPR119KDM1AMEN1KMT2ACYP2C9
SCHEMBL1795627 0.82 GPR119 (0.43) GPR119KDM1AMEN1KMT2ACYP2C9
SCHEMBL25969334 0.82 GPR119 (0.43) GPR119KDM1AMEN1KMT2ACYP2C9
SCHEMBL3538308 0.81 GPR119 (0.43) GPR119KDM1AMEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008018639-A2 GLYCINE TRANSPORTER INHIBITOR TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-02-14 WO disclosed